630 related articles for article (PubMed ID: 32789468)
1. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
2. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
3. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.
Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B
Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153
[TBL] [Abstract][Full Text] [Related]
7. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
Zhao E; Bai X
Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
9. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
11. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
14. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T
Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173
[TBL] [Abstract][Full Text] [Related]
15. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
16. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract][Full Text] [Related]
17. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.
Li Q; Yang W; Lu M; Zhang R
Med Sci Monit; 2020 Dec; 26():e927078. PubMed ID: 33296352
[TBL] [Abstract][Full Text] [Related]
19. A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.
Zhang C; Wang F; Guo F; Ye C; Yang Y; Huang Y; Hou J; Tian F; Yang B
Urol Oncol; 2020 Mar; 38(3):74.e1-74.e11. PubMed ID: 31952997
[TBL] [Abstract][Full Text] [Related]
20. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]